Pricing Log in Create free account

Cue Biopharma, Inc. (CUE) vs Tiziana Life Sciences Ltd (TLSA)

Cue Biopharma, Inc. and Tiziana Life Sciences Ltd are both Biotechnology companies. Cue Biopharma, Inc. and Tiziana Life Sciences Ltd are of similar size ($135.6M and $134.7M). Tiziana Life Sciences Ltd has the higher net margin (0.00% vs −435.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Tiziana Life Sciences Ltd leads on 7 and Cue Biopharma, Inc. on 3.

Valuation

Metric CUE TLSA Biotechnology median
P/E n/m n/m 8.42
P/S 3.14 n/m 10.01
P/B 51.25 n/m 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m 0.04 0.61
EV/Sales 2.73 n/m 9.41
Earnings yield (144.73%) (50.37%) (31.85%)
Free cash flow yield (42.34%) 0.00% (24.58%)

Profitability

Metric CUE TLSA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (262.03%) — 0.00%
Net margin (435.83%) 0.00% 0.00%
Free cash flow margin (133.13%) 0.00% 0.00%
Return on equity (1,603.48%) 0.00% (56.36%)
Return on assets (459.60%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CUE TLSA Biotechnology median
Revenue growth (TTM) 354.37% — 6.02%
EPS growth (last fiscal year) 61.11% (45.45%) 30.26%
Revenue growth, 5-year CAGR 54.16% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CUE TLSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 0.76 4.72
Net debt to EBITDA 1.10 0.19 0.96

Dividend

Metric CUE TLSA Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric CUE TLSA Biotechnology median
Market cap 135.63m 134.73m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack